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Abstract: Different surveillance studies (2005–2015) in northwest Spain revealed the presence of
eae-positive isolates of Escherichia coli O153:H10 in meat for human consumption, poultry farm, wildlife
and human diarrheagenic samples. The aim of this study was to explore the genetic and genomic
relatedness between human and animal/meat isolates, as well as the mechanism of its persistence.
We also wanted to know whether it was a geographically restricted lineage, or whether it was also
reported elsewhere. Conventional typing showed that 32 isolates were O153:H10-A-ST10 fimH54,
fimAvMT78, traT and eae-beta1. Amongst these, 21 were CTX-M-32 or SHV-12 producers. The PFGE
XbaI-macrorestriction comparison showed high similarity (>85%). The plasmidome analysis revealed
a stable combination of IncF (F2:A-:B-), IncI1 (STunknown) and IncX1 plasmid types, together with
non-conjugative Col-like plasmids. The core genome investigation based on the cgMLST scheme
from EnteroBase proved close relatedness between isolates of human and animal origin. Our results
demonstrate that a hybrid MDR aEPEC/ExPEC of the clonal group O153:H10-A-ST10 (CH11-54) is
circulating in our region within different hosts, including wildlife. It seems implicated in human
diarrhea via meat transmission, and in the spreading of ESBL genes (mainly of CTX-M-32 type).
We found genomic evidence of a related hybrid aEPEC/ExPEC in at least one other country.
Keywords: Escherichia coli; ESBL; hybrid pathotype; ExPEC; EPEC; MDR; ST10; O153; EnteroBase
1. Introduction
Escherichia coli is a normal inhabitant of the human and animal intestinal tract. However, E. coli can
also act as a pathogen in a broad range of conditions, from enteric diseases to extraintestinal infections,
such as urinary tract infection (UTI) and sepsis, among others. Strains that cause enteric disease or
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diarrhea are called diarrheagenic E. coli (DEC), which includes six major categories characteristically
defined by certain pathotype-specific virulence markers [1,2]. Thus, the enteropathogenic E. coli (EPEC)
category is typically carrier of the eae gene, as part of the pathogenicity island locus of enterocyte
effacement (LEE), codifying a protein called intimin. The intimin is responsible for the intimate
adherence of the bacteria to the enterocyte membranes and, eventually, for the attaching and effacing
(AE) lesion of the brush-border microvilli [3]. The variable C-terminal-encoding sequence of eae defines
more than 30 distinct intimin types and subtypes associated with tissue tropism [4,5]. EPEC are further
classified as typical (tEPEC) when they carry an EPEC adherence factor (EAF) plasmid that encodes
adherence mediated by the bundle forming pilus (BFP), while atypical EPEC (aEPEC) produce the
AE lesion, but do not express BFP [4,6]. Currently, aEPEC isolates are emerging enteropathogens
detected worldwide and isolated from different niches (animal species, environment, and food samples),
while the main reservoir of tEPEC isolates are humans [7,8]. On the other hand, E. coli that cause
extraintestinal infections are referred to as extraintestinal pathogenic E. coli (ExPEC), which includes a
heterogeneous group of pathotypes defined by isolation from infections outside the intestinal tract:
uropathogenic E. coli (UPEC), avian pathogenic E. coli (APEC), and neonatal meningitis E. coli (NMEC).
A variety of specific virulence genes have been described in ExPEC (adhesins, protectins, siderophores,
toxins, hemolysins, polysaccharide antigens, invasins, colicins, etc.) [1,2]. However, even though
certain virulence traits and phylogenetic groups have been proposed to characterize ExPEC [9,10], no
set of genes can be used to unequivocally distinguish them from commensal E. coli. In fact, ExPEC
strains can commensally colonize the human intestine, which in turn, can serve as reservoir [11].
Antimicrobial resistance is a serious global concern which involves the health care system, food
production and environmental integrity [12]. In fact, it is assumed that antimicrobial drugs used
in the livestock sector play an important role in the spread of extended-spectrum beta-lactamases
(ESBL)-producing E. coli throughout the food chain to humans [13,14]. The genomic plasticity of E. coli
is the consequence of the important role played by mobile genetic elements (MGEs) such as plasmids,
bacteriophages, pathogenicity islands, transposons and insertion sequence elements in the evolution
of the bacteria [15]. As a result, hybrid E. coli pathotypes unpredictably emerge, given the mobility of
most of the genes encoding virulence and antimicrobial resistance (AMR) [15,16]. Since 2011, when a
novel Shiga-toxin-producing E. coli (STEC) belonging to serotype O104:H4, with virulence features
(VF) common to the enteroaggregative E. coli (EAggEC ) and CTX-M-15 producer was identified as
the one involved in the large German outbreak [17], the concept of pathotype has been questioned.
Currently, classical and new approaches, such as whole genome sequencing (WGS), are being used to
enhance the understanding of the evolution of this highly adaptable species [16,18].
Different in-house surveillance studies in northwest Spain (2005-2015) revealed the presence of
eae-positive isolates of E. coli O153:H10, many of them ESBL-producers, in meat for human consumption,
wildlife, and avian farm environments. We also found them involved in human diarrhea. The aim of
this study was to explore the genetic and genomic characterization relatedness between human and
animal/meat isolates, as well as to gain knowledge in the mechanism that might be playing a role in
its persistence. We also wanted to know whether it was a geographically restricted E. coli lineage, or
whether it was also reported somewhere else.
2. Results
Thirty-two eae-positive E. coli (21 ESBL and 11 non-ESBL) belonging to the serotype O153:H10
constituted the collection of the study: 14 from human stools, 8 from beef meat, 7 from chicken meat,
and 1 each from pork meat, wildlife (fox feces) and a poultry farm environment sample, as shown
in Table S1. They were detected within different surveys from 2005 to 2015 based on the following
findings. First, we noticed the recovery of eae-positive isolates with the same intimin type. Second,
many of them were ESBL-producers (coming from surveillance studies on ESBL-producing E. coli
in animal sources). Third, they belonged to the O153 serogroup. Fourth, we found them within the
human collection in the retrospective analysis. Fifth, the isolates also carried ExPEC virulence genes.
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2.1. Conventional Typing
Table 1 summarizes the main traits obtained by conventional typing for the 32 isolates. All were
positive for the intimin eae-beta1, but negative for bfpA gene, conforming the aEPEC pathotype. Other
virulence genes defining verotoxigenic (VTEC), enteroinvasive (EIEC), enteroaggregative (EAggEC) or
enterotoxigenic (ETEC) pathotypes were not detected. Interestingly, the investigation of virulence traits
associated with ExPEC showed that the fimAvMT78 gene, which is a virulence locus that codify a fimA
variant MT78 of type 1 fimbriae [19], was present in all isolates. In addition, the traT gene that codifies
an outer membrane protein implicated in serum survival [20] was also determined in 17 of the isolates,
as shown in Table 1. Finally, all the isolates were assigned to the clonal group O153:H10-A-ST10
(CH11-54) by means of the serotyping, phylogroup, MLST and clonotyping.
The highest rates of AMR were to: ampicillin (75%; 24/32), cefuroxime (68.7%; 22/32), cefotaxime
(65.6%, 21/32), ceftazidime (65.6%, 21/32), cefepime (59.4%, 19/32) and gentamicin (59.4%, 19/32). The
ESBL-typing of the 21 positive isolates determined that 19 were CTX-M-32 and two SHV-12 producers,
as shown in Table 1.
The comparison of the XbaI-macrorrestriction profiles obtained by pulsed field gel electrophoresis
(PFGE) of the ESBL-producing aEPEC isolates revealed high similarity. Thus, all but one clustered
with an identity >85% in the dendrogram shown in Figure 1. It is of note that three human clinical
isolates, recovered in different years, clustered each with a fox (95.2% of similarity) and with two beef
meat isolates (100% and 97.6% of similarity, respectively).
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Table 1. Phenotypic and genotypic characterization of 32 aEPEC O153:H10-A-ST10 (CH11-54) isolates.
Sample Origin Code a Year Geographic Origin Virulence Gene Profile Resistance Profile b blaESBL Type
Pork meat *LREC-122 2011 Lugo fimH54, fimAvMT78, traT, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN CTX-M-32
Chicken meat *LREC-115 2009 Lugo fimH54, fimAvMT78, traT, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB CTX-M-32
Chicken meat FV 19517 2009 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN CTX-M-32
Chicken meat *LREC-118 2009 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN CTX-M-32
Chicken meat *LREC-110 2010 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN CTX-M-32
Chicken meat FV 14703 2010 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB, FOF CTX-M-32
Chicken meat LREC-126 2010 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB CTX-M-32
Chicken meat *LREC-123 2010 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB CTX-M-32
Beef meat *LREC-119 2007 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN CTX-M-32
Beef meat * LREC-117 2007 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN CTX-M-32
Beef meat 4-3a 2007 Lugo fimH54, fimAvMT78, traT, eae-beta1 AMP, CXM, CTX, CAZ SHV-12
Beef meat 85-5a 2008 Lugo fimH54, fimAvMT78, traT, eae-beta1 AMP, GEN −
Beef meat *LREC-125 2008 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, FEP CTX-M-32
Beef meat *LREC-114 2008 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB CTX-M-32
Beef meat 65-6a 2009 Lugo fimH54, fimAvMT78, traT, eae-beta1 − −
Beef meat *LREC-120 2011 Lugo fimH54, fimAvMT78, traT, eae-beta1 AMP, CXM, CTX, CAZ, FEP SHV-12
Wildlife (Fox) *LREC-111 2015 Lugo fimH54, fimAvMT78, traT, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB CTX-M-32
Poultry farm *LREC-127 2010 Pontevedra fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN CTX-M-32
Human *LREC-116 2006 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB CTX-M-32
Human *LREC-113 2007 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB CTX-M-32
Human *LREC-121 2007 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB CTX-M-32
Human *LREC-124 2007 Lugo fimH54, fimAvMT78, eae-beta1 AMP, CXM, CTX, CAZ, FEP, GEN, TOB CTX-M-32
Human 31952. 07 2007 Lugo fimH54, fimAvMT78, traT, eae-beta1 − −
Human 32651. 07 2007 Lugo fimH54, fimAvMT78, traT, eae-beta1 NAL, CIP −
Human 32884. 07 2007 Lugo fimH54, fimAvMT78, traT, eae-beta1 AMP, CXM, CAZ, AMC, SXT −
Human 34535. 07 2007 Lugo fimH54, fimAvMT78, traT, eae-beta1 NAL, CIP −
Human 39044. 07 2007 Lugo fimH54, fimAvMT78, traT, eae-beta1 − −
Human 21011. 08 2008 Lugo fimH54, fimAvMT78, traT, eae-beta1 − −
Human 38506. 08 2008 Lugo fimH54, fimAvMT78, traT, eae-beta1 CIP −
Human 40237. 08 2008 Lugo fimH54, fimAvMT78, traT, eae-beta1 NAL, CIP −
Human *LREC-112 2011 Santiago de Compostela fimH54, fimAvMT78, traT, eae-beta1 AMP, CXM, CTX, CAZ, FEP, NAL CTX-M-32
Human 55515.12 2012 Lugo fimH54, fimAvMT78, traT, eae-beta1 AMP, GEN −
a Strains marked with (*) were further analyzed by WGS; b ampicillin (AMP), amoxicillin/clavulanic acid (AMC), cefuroxime (CXM), ceftazidime (CAZ), cefotaxime (CTX), cefepime (FEP),
cefoxitin (FOX), gentamicin (GEN), tobramycin (TOB), fosfomycin (FOF), sulfamethoxazole/trimethoprim (SXT), ciprofloxacin (CIP) and nalidixic acid (NAL).
Antibiotics 2020, 9, 192 5 of 19
2.2. Whole Genome Sequencing (WGS)
Based on the high similarity shown by PFGE and to further investigate the virulence profile,
resistome, plasmid content and relatedness, 17 representative aEPEC/ExPEC isolates were WG
sequenced. The de novo assembled contigs were typed in silico using the EnteroBase tools, as shown
in Table S2, as well as the Center for Genomic Epidemiology (CGE) databases, also shown in Table 2.
SerotypeFinder and EnteroBase predictions corroborated O and H antigens, with the exception of
LREC-120 and LREC-121, for which O153 was solved by serotyping. MLST (CGE and EnteroBase),
CHTyper and ClermonTyping also confirmed conventional data for ST (10), CH (11-54) and phylogroup
(A), shown in Table 2 and Table S2. Additionally, the wgST, cgST, and rST of the genomes were
determined using the schemes of EnteroBase, shown in Table S2. Whole genome multilocus sequence
typing (WgMLST) and core genome multilocus sequence typing (cgMLST) are powerful schemes with
extreme and high resolution, respectively. cgMLST is defined as MLST based on the core genome,
whereas wgMLST is based on a non redundant set of genes across a species, similar to a ‘pan-genome’.
In EnteroBase, the number of core loci included in the cgMLST scheme for E. coli is 2,512 and 25,002 in
the wgMLST. Different cgSTs and wgSTs were assigned to each of the 17 genomes analyzed, while
rST (medium resolution; 53 loci) was the same (2021) for all genomes, excluding LREC-127 (58738), as
shown in Table S2.
VirulenceFinder corroborated the hybrid pathotype nature of the isolates, predicting in all genomes
the eae gene (intimin) together with other components encoded in the LEE pathogenity island, as well
as the increased serum survival gene iss recognized for its role in ExPEC virulence [21]. The astA gene,
which encodes the heat-stable enterotoxin 1, was also present in all 17 isolates (Table 2).
ResFinder identified the genes associated to resistances observed in vitro (acquired resistances
for beta-lactams, aminoglycosides, and point mutations for quinolones), only, the blaCTX-M-32 was
not predicted in silico for LREC-112 and LREC-119, but by conventional sequencing. Furthermore,
ResFinder determined other acquired resistances which had not been tested in vitro, such as to
phenicols and macrolides in all genomes, and to tetracyclines in 16 out of the 17 genomes, as shown in
Table 2.
Based on the replicon identification, PlasmidFinder revealed a homogenous profile of four or
five plasmid types. Thus, the concomitant presence of IncF (F2:A-:B-), IncI1 (STunknown) and IncX1,
together with non-conjugative Col156-like plasmids, was detected in 15 of 17 genomes. Four of those
15 genomes were also carriers of Col (MG828)-like plasmids, as shown in Table 2.
In the asymmetric distance matrix on the cgMLST scheme from EnteroBase, based on the presence
or absence of 2,513 genes, the 17 genomes showed <20 differences (range 5–19) in relation to the human
diarrheagenic isolate LREC-113, as displayed in Table 3 and Figure 2. We also looked into the static
Hierarchical Clustering (HierCC) designations in EnteroBase. The 17 genomes were assigned into the
same HierCC HC50 (37600), which means all strains in this cluster have links no more than 50 alleles
apart. Furthermore, using HC20, three human genomes (LREC-113, LREC-116, LREC-124) and two
beef meat (LREC-119, LREC-125) clustered together (37606) with links no more than 20 alleles apart, as
shown in Table S3. A dendrogram was also built in EnteroBase based on the SNPs of the core genomic
regions present in 90% of the compared genomes, and using LREC-113 as reference, downloaded, and
modified with FigTree v1.4.3 as shown in Figure 3. Within 1,068 variant sites, the number of SNPs was
<62 for 13 of the 17 genomes, as displayed in Table S3.
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Table 2. In silico characterization of 17 Escherichia coli genomes from the study collection using Center for Genomic Epidemiology (CGE) databases and ClermonTyping
(in red, results obtained only by conventional typing).
Code Serotype 1 Phylo Group 2
CHType
3 ST 4
Plasmid Content Inc
Group (pMLST) 5
Acquired Resistances (black) and
Point Mutations (blue) 6 Virulence Genes
7,8
LREC-110 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, espF,
gad, iss, mchF, nleA, tccP, tir
LREC-111 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
Col (MG828)
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, gad, iss,
mchF, nleA, tccP, tir
LREC-112 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncX1
Col156
Col (MG828)
blaCTX-M-32; aadA1; catA1; mdf(A);
tet(A); gyrA S83L
astA, eae, espA, espB, espF,
gad, iss, mchF, nleA, tccP
LREC-113 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, espF,
gad, iss, mchF, tir
LREC-114 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
Col (MG828)
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, espF,
gad, iss, mchF, nleA, tir
LREC-115 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, espF,
gad, iss, mchF, nleA, tccP, tir
LREC-116 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, gad, iss,
mchF, tccP, tir
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Table 2. Cont.
Code Serotype 1 Phylo Group 2
CHType
3 ST 4
Plasmid Content Inc
Group (pMLST) 5
Acquired Resistances (black) and
Point Mutations (blue) 6 Virulence Genes
7,8
LREC-117 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
blaCTX-M-32; aadA1; mdf(A); tet(A)
astA, eae, espA, espB, gad, iss,
mchF, tccP, tir
LREC-118 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
Col(MG828)
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, espF,
gad, iss, mchF, nleA, tccP, tir
LREC-119 O153:H10 A 11-54 10 Col156 blaCTX-M-32, aadA1; catA1; mdf(A)
astA, eae, espA, espB, gad, iss,
nleA, tccP, tir
LREC-120 O153:H10 A 11-54 10
IncI1 (ST22-CC2)
IncQ1
IncX1
Col156
Col (MG828)
blaSHV-12; aadA1, aadA2; catA1, cmlA1;
mdf(A); sul3; tet(A)
astA, eae, espA, espB, gad, iss,
mchF, nleA, tccP, tir
LREC-121 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, gad, iss,
mchF, nleA, tccP, tir
LREC-122 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
Col (MG828)
blaCTX-M-32; aac(3)-IIa, aadA1; catA1;
mdf(A); tet(A)
astA, eae, espA, espB, gad, iss,
mchF, nleA, tccP, tir
LREC-123 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
Col (MG828)
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, gad, iss,
mchF, nleA, tccP, tir
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Table 2. Cont.
Code Serotype 1 Phylo Group 2
CHType
3 ST 4
Plasmid Content Inc
Group (pMLST) 5
Acquired Resistances (black) and
Point Mutations (blue) 6 Virulence Genes
7,8
LREC-124 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
IncY
Col156
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, espF,
gad, iss, mchF, tccP, tir
LREC-125 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
blaCTX-M-32; aadA1; catA1; mdf(A);
tet(A)
astA, eae, espA, espB, espF,
gad, iss, mchF, nleA, tccP, tir
LREC-127 O153:H10 A 11-54 10
IncF (F2:A-:B-)
IncI1 (STunknown)
IncX1
Col156
Col (MG828)
blaCTX-M-32, blaTEM-1A; aac(3)-IIa,
aadA1; catA1; mdf(A); tet(A)
astA, eae, espA, espB, espF,
gad, iss, mchF, nleA, tccP, tir
1 Serotypes, 3 clonotypes, 4 sequence types, 5 replicon/plasmid STs, 6 acquired antimicrobial resistance genes and/or chromosomal mutations, 7 virulence genes were determined using
SerotypeFinder 2.0, CHtyper 1.0, MLST 2.0, PlasmidFinder 2.0, pMLST 2.0, ResFinder 3.1 and VirulenceFinder 2.0 online tools at the CGE, respectively. While 2 phylogroups were predicted
using the ClermonTyping tool at the Iame-research Center web. 1 Serotypes: underlined and in red those (LREC-121, LREC-120) that were not predicted (ONT) by SerotypeFinder but
assigned as O153 by conventional typing. 6 Resistome: Acquired resistance genes: beta-lactam: blaTEM-1A, blaCTX-M-32, blaSHV-12; aminoglycosides: aac(3)-IIa, aadA1, aadA2; phenicols: catA1,
cmlA1; macrolides: mdf(A); sulphonamides: sul3; tetracycline: tet(A). Point mutations (marked in blue): quinolones and fluoroquinolones: gyrA S83L: TCG-TTG. Underlined and in red
those blaCTX-M-32 genes (LREC-112, LREC-119) that were not predicted by ResFinder but determined in conventional typing 8 Virulence genes: astA: EAST-1, eae: intimin, espA: type III
secretions system, espB: secreted protein B, espF: type III secretions system, gad: glutamate descarboxylase, iss: increased serum survival, mchF: ABC transporter protein MchF, nleA:
non-LEE-encoded effector A, tccP: Tir cytoskeleton coupling protein, tir: translocated intimin receptor protein. bp: base pairs; CHType: clonotype (fumC-fimH); ST: sequence type according
to Achtman scheme; pMLST: plasmid sequence type.
Antibiotics 2020, 9, 192 9 of 19
Table 3. Asymmetric distance matrix based on the cgMLST scheme from EnteroBase in which D (a, b) equals all sites that are present in (b) and different from (a).
Genome Code/
cgMLST
LREC-
110
LREC-
111
LREC-
127
LREC-
112
LREC-
113
LREC-
120
LREC-
117
LREC-
121
LREC-
119
LREC-
116
LREC-
115
LREC-
114
LREC-
123
LREC-
122
LREC-
124
LREC-
125
LREC-
118
37600 37601 37602 37605 37606 37607 37609 37610 37611 37612 37613 37614 37615 37616 37617 37618 38299
LREC-110 37600 0 14 17 19 13 12 18 19 12 15 27 8 15 15 18 16 14
LREC-111 37601 14 0 21 23 16 20 22 23 16 19 30 11 19 18 22 20 17
LREC-127 37602 17 21 0 24 9 22 14 16 9 11 24 15 13 13 15 13 13
LREC-112 37605 19 23 24 0 19 25 24 25 18 21 33 17 22 22 24 23 21
LREC-113 37606 13 16 9 19 0 18 9 11 5 6 18 10 9 8 11 9 8
LREC-120 37607 12 20 22 25 18 0 23 23 18 20 33 14 20 20 24 22 19
LREC-117 37609 18 22 14 24 9 23 0 17 8 12 22 15 14 13 14 12 13
LREC-121 37610 19 23 16 25 11 23 17 0 10 13 25 15 16 16 16 14 14
LREC-119 37611 12 16 9 18 5 18 8 10 0 6 17 10 9 9 7 6 8
LREC-116 37612 15 19 11 21 6 20 12 13 6 0 22 12 11 11 13 11 10
LREC-115 37613 27 30 24 33 18 33 22 25 17 22 0 22 24 23 23 15 20
LREC-114 37614 8 11 15 17 10 14 15 15 10 12 22 0 13 12 15 14 11
LREC-123 37615 15 19 13 22 9 20 14 16 9 11 24 13 0 7 15 13 8
LREC-122 37616 15 18 13 22 8 20 13 16 9 11 23 12 7 0 15 13 9
LREC-124 37617 18 22 15 24 11 24 14 16 7 13 23 15 15 15 0 12 14
LREC-125 37618 16 20 13 23 9 22 12 14 6 11 15 14 13 13 12 0 12
LREC-118 38299 14 17 13 21 8 19 13 14 8 10 20 11 8 9 14 12 0
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3. Discussion
The recovery from different sources of eae-positive E. coli isolates of serotype O153:H10, and its
association with ESBL enzymes triggered this investigation. In independent studies on ESBLs in our
region, we found that O153 aEPEC represented 5.5% of the ESBL-producing E. coli recovered from
chicken meat (2009-2010), 7.7% of pork meat (2011-2012), 20% of beef meat (2011-2012), 1% of poultry
farm environments (2010-2012) and 1% of wildlife feces (2014-2015) [22]. In addition, we detected 23
(0.24%) O153 aEPEC as the only pathogen within 9,523 stools of epidemiologically unrelated patients
(2006–2012) in the routine testing of human diarrheagenic samples. From those 23, 14 (0.15%) were
O153:H10 eae-beta1 fimAvMT78, and five of them CTX-M-32 producers, as shown in Tables S4 and S5
and Figure 1. By conventional typing, all animal and human isolates were assigned to the clonal group
O153:H10-A-ST10 (CH11-54), conforming a hybrid aEPEC/ExPEC pathotype not previously described.
The symptomatology reported in humans was mainly mild diarrhea, but there were also some cases of
acute and hemorrhagic gastroenteritis, as shown in Table S5. Epidemiological studies have indicated
that aEPEC are emerging enteropathogens, implicated in human diarrhea, with higher prevalence
than tEPEC in both developed and developing countries [23]. aEPEC are present in both healthy
and diseased animals and humans [8,24,25], are phylogenetically heterogeneous, and carry virulence
factors of other diarrheagenic E. coli more often than tEPEC strains [6,23,26]. However, the main feature
of the EPEC diarrheagenic group is the ability to induce A/E lesions on intestinal epithelium encoded in
the chromosomal pathogenicity island LEE. Within more than 30 intimin types and subtypes based on
the polymorphism of eae, the subtype determined here (beta-1) is first or second in prevalence within
different studies on isolates from humans with diarrhea in Spain [24], Australia [27], Brazil [28,29],
Peru [30] or China [31].
It is of note that in subsequent and current studies, we have detected this clonal group on meat
samples from supermarkets in our city. In fact, we recovered aEPEC/ExPEC from 15 out of 100 poultry
meat samples (2016-2017), and of those, five were carriers of isolates belonging to the clonal group
O153:H10-A-ST10, including one CTX-M-32 producer (unpublished data). Recently, Zhang et al. [32]
reported a 2.75% prevalence of aEPEC in retail foods at markets in the People’s Republic of China,
with the beta-1 intimin and the ST10, as the second intimin and ST most prevalent within their isolates.
According to the authors, the presence of virulent and MDR aEPEC in retail foods poses a potential
threat to consumers. While O153 is a serogroup reported within ExPEC and DEC isolates, and linked
to different lineages [33–36], there are few references of the serotype O153:H10. Notheworthy, the
report by Schremmer et al [37] of an aEPEC O153:H10 isolated from the small intestine of a cockatiel
(psittaciform bird) with enteritis.
Since the occurrence of the major outbreak of HUS in Europe in 2011 caused by an EAggEC/STEC
O104:H4, other hybrid pathotypes have been recognized and new ones are expected, either by novel
assemblies of E. coli virulence determinants or through the acquisition of new virulence genes from
other bacterial species [16]. In Norway, Lindstedt et al. [38], expressed their concern regarding the
detection of E. coli from human fecal content with a combination of intestinal and ExPEC virulence
genes (IPEC/ExPEC) in a high frequency (64.3%). Several other studies have also identified STEC- and
ETEC-associated virulence genes coexisting in E. coli isolates from humans, animals or environmental
origin [39,40]. However, one of the most outstanding is the EPEC/STEC O80:H2-ST301, which emerged
in France over the last few years and diffused within Europe. This emerging hybrid is associated with
invasive infections, and combines intestinal VFs (stx2d, eae-xi and ehxA genes) and extraintestinal genes
characteristic of the plasmid pS88 [41,42]. In this O80 clone, it is to highlight the location of MDR
and pS88 genes in the same plasmid, as well as the presence of two additional plasmids (a carrier of
ehxA gene and a cryptic one) within the isolates [41,42]. The clonal group described here poses also
the threat of being MDR and characteristically associated with ESBL-type CTX-M-32. The CTX-M-32
enzyme is derived from CTX-M-1 by a single amino acid replacement, probably an ancestor among
CTX-M-1 and CTX-M-15 [43]. The blaCTX-M-32 gene was first described in 2004 in an Escherichia coli
isolate in our Health Area (A Coruña, northwest Spain) [43]. Furthermore, it was described in three
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human isolates O25b:H4-ST131 ibeA-positive of our region, as early as in 2008 [14]. Of the 2,427 E.
coli bloodstream isolates recovered in the hospital of our city (HULA) in the period 2000–2011, 96
were positive for ESBL production, from which 4.2% were CTX-M-32 and 4.2% SHV-12 [44]. The same
prevalence was observed in this hospital in 2015 (unpublished data).
The in silico analysis of 17 representative genomes O153:H10-A-ST10 corroborated the main traits
determined by conventional typing. In a recent study, we proved the good correlation and usefulness
of SerotypeFinder or EnteroBase predictions [25,45]. Here, only the serotype of two genomes could
not be predicted in silico, probably due to the limitation of the assembly based on Illumina short
reads [46]. MLST, CHTyper from CGE and EnteroBase also confirmed conventional results. Like in
the previous study, we found that VirulenceFinder verified the E. coli pathotypes (aEPEC/ExPEC)
established by PCR. However, VirulenceFinder identified different traits for the ExPEC pathotype.
Thus, this clonal group O153:H10-A-ST10 typically carries the locus encoding a fimA variant MT78 of
type 1 fimbriae [19], and the traT gene for an outer membrane protein implicated in serum survival [20].
Both VFs are not included in the VirulenceFinder scheme and so, they are not predicted. On the
contrary, the CGE tool allowed the identification of the increased serum survival gene iss, recognized
for its role in ExPEC virulence [21], in all genomes. The CGE database predicts 14 variants of the iss
gene [47], including the one described in E. coli IAI1 (CU928160), and harbored by the O153:H10-A-ST10
genomes. Our specific PCR detects the plasmid-borne iss allele (designated type 1), which is highly
prevalent among avian pathogenic E. coli and neonatal meningitis-associated E. coli isolates, but not
among uropathogenic E. coli isolates [21]. The phenotypic AMR determined in vitro correlated with
the results predicted by ResFinder databases, with the exception of the blaCTX-M-32 gene not predicted
in two genomes, but solved by PCR and sequencing. Based on this, and previous studies [45,48], we
consider both conventional and genomic-based analysis complementary for a better understanding
and characterization of emerging isolates.
An important trait found in this study was the concomitant presence of IncF (F2:A-:B-), IncI1
(STunknown) and IncX1, together with non-conjugative Col156-like plasmids in 15 of the 17 genomes.
Although carriage of plasmids places a fitness burden on their host [49], different studies support
the hypothesis that interference between conjugative plasmids may reduce fitness cost by decreasing
the efficiency of transfer. However, the mechanisms of such inhibitory systems need further
investigation [50]. On the other hand, small plasmids were shown to increase their stability in
cells containing big plasmids [49]. We hypothesized here that the stable combination of IncF (F2:A-:B-),
IncI1 (STunknown) and IncX1 plasmid types, together with non-conjugative Col-like types might
be implicated in the successful persistence of this hybrid pathotype, and the spread of antibiotic
resistance genes.
Another objective in this study was to know if this was a geographically restricted genetic lineage,
or if it had been reported somewhere else. For this purpose, and based on the HierCC Cluster ID, we
searched related genomes uploaded in EnteroBase. As a result, we found a hybrid aEPEC/ExPEC
pathotype A-ST10 eae-beta1 on its database associated to five humans, one avian, and one unknown
isolates, as shown in Table S3. Of note are the two human O153:H10-A-ST10 (CH11-54) eae-beta1
isolates (Code Name: 853984 and 866428) from the United Kingdom, which clustered with the 17
Spanish genomes in the HC100 HierCC group (37600), as shown in Table S3 and Figure S1. Additionally,
the in silico analysis of these two genomes showed that they were MDR, and carried similar virulence
traits (conforming hybrid aEPEC/ExPEC pathotype) and plasmid combination: IncF (F2:A-:B-), IncX1
and Col156-like, as shown in Table S6. Importantly, six of the seven hybrid aEPEC/ExPEC genomes
found in EnteroBase were carriers of IncF (F2:A-:B-) and Col156-like plasmids, as shown in Table S6.
As above suggested, further investigation on the interplay between these plasmids and other mobile
genetic elements affecting their transmission and persistence, as well as their role in the maintenance
and acquisition of resistance genes is necessary.
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4. Materials and Methods
4.1. E. coli Collection
From 2005 to 2015, different surveillance studies performed at the Reference Laboratory of
Escherichia coli (LREC), in Lugo, Spain, aimed to detect ESBL-producing E. coli within different sources
of our region. These studies included samples from chicken, beef and pork meat, as well as poultry
farm environments (avian feces taken from the floor) and wildlife (fox feces). Briefly, the confluent
growth of the MacConkey Lactose plates from each sample was screened by PCR for the presence of
specific bla genes using the TEM, CIT, SHV, CTX-M-1 and CTX-M-9 group-specific primers [51]. Then,
up to ten individual colonies from positive plates were reanalyzed. Those confirmed for the bla genes
were further characterized by PCR for the presence of VF eae, stx1, stx2, ipaH, pcDV432, eltA, estA or
estB associated with the main intestinal pathotypes (enteropathogenic, verotoxigenic, enteroinvasive,
enteroaggregative and enterotoxigenic) of E. coli. Likewise, specific extraintestinal VF were tested:
fimH, fimAvMT78, papC, sfa/focDE, afa/draBC, cnf1, cdtB, sat, hlyA, iucD, iroN, kpsM II (establishing neuC-K1,
K2 and K5 variants), kpsM III, cvaC, iss, traT, ibeA, malX, usp and tsh (Tables S7–S9).
On the other hand, human diarrheagenic E. coli isolates, mainly from the Hospital Universitario
Lucus Augusti (HULA) of our city (Lugo, northwest Spain), were routinely analyzed in our laboratory
for intestinal VF, and those positive, complementary analyzed for extraintestinal traits and ESBL genes,
as described in the preceding paragraph.
All isolates were serotyped using the method previously described by Guinée et al. [52] employing
O1 to O185 and H1 to H56 antisera. As a result, 32 eae-positive E. coli (21 ESBL and 11 non-ESBL)
belonging to the serotype O153:H10 constituted the collection of the study, as shown in Table S1.
4.2. Antimicrobial Susceptibility and ESBL Typing
Antimicrobial susceptibility testing was conducted by disk (Becton Dickinson, Sparks, MD, USA)
diffusion assay. The antibiotics tested included ampicillin (AMP), amoxicillin/clavulanic acid (AMC),
cefuroxime (CXM), ceftazidime (CAZ), cefotaxime (CTX), cefepime (FEP), cefoxitin (FOX), aztreonam
(ATM), imipenem (IMP), gentamicin (GEN), tobramycin (TOB), fosfomycin (FOF), nitrofurantoin
(NIT), sulfamethoxazole/trimethoprim (SXT), ciprofloxacin (CIP) and nalidixic acid (NAL). The assays
were performed, and all results interpreted, according to the CLSI guidelines [53]. The isolates were
investigated by PCR for screening of specific bla genes using the TEM, SHV, CTX-M-1 and CTX-M-9
group-specific primers (Table S9), and further sequencing as described elsewhere [51].
4.3. Phylogenetic Assignment and PFGE Comparison
Phylogroup and ST assignment was performed following the Clermont et al. [54] and Achtman
MLST [55] schemes, respectively. The clonotyping was based on the internal 469-nucleotide (nt)
and 489-nt sequence of the fumC and fimH genes, respectively, to define the CH type [56]. The
molecular similarity within the collection was established by comparing the XbaI-PFGE profiles of the
isolates obtained following the PulseNet protocol, and imported into BioNumerics (Applied Maths,
St-Martens-Latem, Belgium) to perform a dendrogram with the UPGMA algorithm based on the Dice
similarity coefficient and applying 1% of tolerance in the band position.
4.4. Genome Sequencing, Assembly and Analysis
DNA from 17 isolates was extracted with the QIAamp 96 DNA Qiacube HT kit (Qiagen, Hilden,
Germany) and libraries were prepared using the Nextera XT kit (Illumina). Pooled libraries were
denatured following the Illumina protocol and 600 µl (approx. 20 pM) were loaded onto a MisSeq
V2 -500 cycle cartridge (Illumina) and sequenced on a MiSeq to produces fastq files. Raw reads were
uploaded and automatically assembled in EnteroBase using SPAdes Genome Assembler v 3.5. with
a contig threshold of minimum 200 nucleotides. Subsequently, the de novo assembled contigs were
MLST (7 gene Achtman ST scheme, whole genome MLST, core genome MLST and ribosomal MLST)
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and serotyped in silico using EnteroBase typing tools [57]. The raw reads were also analyzed using
the following CGE databases: SerotypeFinder, MLSTtyper, CHTyper, PlasmidFinder, ResFinder, and
VirulenceFinder [58–62]. For genomic relatedness comparison, we used different approaches based
on the cgMLST of EnteroBase. Thus, a MSTree was inferred using the MSTree V2 algorithm and the
asymmetric distance matrix based on the cgMLST scheme from EnteroBase. This cgMLST scheme
consists of 2,513 genes present in over 98% of 3,457 genomes, which represented most of the diversity
in EnteroBase https://enterobase.readthedocs.io/en/latest/pipelines/escherichia-statistics.html. We also
investigated the HierCC designations for our collection and other related genomes of EnteroBase
within each cluster group [57,63]. The SNP tree was also built in EnteroBase, where all assemblies were
aligned against LREC-113 using Last [64], and SNPs from these alignments were filtered to remove
regions with low base qualities or ambiguous alignment. Specifically, any sites with low base qualities
(Q < 10) or sites which could not be aligned unambiguously (ambiguity of alignment ≥ 0.1, as reported
by Last) were excluded. Additionally sites were removed if disperse repetitive regions were aligned
with ≥ 95% identities and longer than ≥ 100 bps according to nucleotide BLAST; if they were part of
tandem repeats that were identified by TRF [65]; if they were within CRISPR regions, which were
identified by PILER-CR [66]. After removing repetitive regions, all core SNPs were then called in the
core genomic regions that were conserved in ≥ 90% of the genomes.
5. Conclusions
In summary, our results demonstrate that a hybrid MDR aEPEC/ExPEC belonging to the clonal
group O153:H10-A-ST10 (CH11-54) eae-beta1 is circulating in our region within different hosts, including
wildlife. It seems implicated in human diarrhea via food (meat) transmission, and in the spreading of
ESBL genes (mainly of CTX-M-32 type). The concomitant presence of IncF (F2:A-:B-), IncI1 (STunknown)
and IncX1, together with non-conjugative Col156-like plasmids might be implicated in the successful
persistence of this hybrid pathotype. We found genomic evidence of a related hybrid aEPEC/ExPEC in
at least one other country.
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